291 results on '"Köhl, Ulrike"'
Search Results
2. Non-viral vectors for chimeric antigen receptor immunotherapy
3. A reliable transcriptomic risk-score applicable to formalin-fixed paraffin-embedded biopsies improves outcome prediction in localized prostate cancer
4. New regulatory thinking is needed for AI-based personalised drug and cell therapies in precision oncology
5. Biological Properties of Cells Other Than HSCs
6. Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma
7. Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CAR NK cells
8. A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation
9. Characterization and evaluation of gene fusions as a measure of genetic instability and disease prognosis in prostate cancer
10. Technologien und Lösungsansätze für die effiziente Herstellung von Zelltherapeutika für die CAR-Immuntherapie
11. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering
12. ATMP: der Weg in die Klinik
13. CAR-T-Zellen als Arzneimittel für neuartige Therapien (Advanced Therapy Medicinal Products)
14. Biological Properties of Cells Other Than HSCs
15. Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation
16. Nicotinamide Inhibits Self-renewal and Induces Granulocyte Differentiation of Multipotent Progenitor Cells
17. The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
18. 329 Redirecting NK cell cytotoxicity by innate cell engagers: a differentiated and innovative approach compared to CAR-NK cells
19. Lipid Nanoparticles (LNPs) outperform Electroporation in mRNA-based CAR T cell Engineering
20. OA-04 Single cell multi-omic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma
21. P-009 Cellular dynamics following CAR T cell therapy are associated with response, resistance and cytokine release syndrome in relapsed/refractory myeloma
22. High-dose vitamin D in Addison's disease regulates T-cells and monocytes: A pilot trial
23. Possible Impact of Cytomegalovirus-Specific CD8+ T Cells on Immune Reconstitution and Conversion to Complete Donor Chimerism after Allogeneic Stem Cell Transplantation
24. Teclistamab impairs detection of BCMA CAR-T cells
25. Efficient Redirection of NK Cells by Genetic Modification with Chemokine Receptors CCR4 and CCR2B
26. Regulation of advanced therapy medicinal products in Europe and the role of academia
27. Multimer monitoring of CMV-specific T cells in research and in clinical applications
28. Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer
29. Treatment of patients with advanced cancer with the natural killer cell line NK-92
30. Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity
31. Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
32. Reply to Bouzani et al
33. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells
34. Time to evolve: predicting engineered T cell-associated toxicity with next-generation models
35. Four decades of experience of prosthetic valve endocarditis reflect a high variety of diverse pathogens
36. GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD2 and Releasing Inducible IL-18
37. Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
38. Human Natural Killer Cells Exhibit Direct Activity Against Aspergillus fumigatus Hyphae, But Not Against Resting Conidia
39. 13. Quantifizierung von Leukozyten- Untergruppen in manipulierten Stammzellund Immunzellpräparaten
40. Automatisierung für die personalisierte Krebstherapie: CAR-T-Zellen gegen malignes Melanom
41. Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells
42. Generation and Characterization of Anti-Candida T Cells as Potential Immunotherapy in Patients with Candida Infection after Allogeneic Hematopoietic Stem-Cell Transplant
43. Natural killer cells to target cancer
44. Ex vivo Pretreatment of Bone Marrow Mononuclear Cells with Endothelial NO Synthase Enhancer AVE9488 Enhances Their Functional Activity for Cell Therapy
45. Taking Lessons from CAR-T Cells and Going Beyond: Tailoring Design and Signaling for CAR-NK Cells in Cancer Therapy
46. Four decades of experience of prosthetic valve endocarditis reflect a high variety of diverse pathogens.
47. Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
48. Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
49. Extracellular Vesicles of Mesenchymal Stromal Cells Can be Taken up by Microglial Cells and Partially Prevent The Stimulation Induced by β-Amyloid
50. Low Energy Electron Irradiation Is a Potent Alternative to Gamma Irradiation for the Inactivation of (CAR-)NK-92 Cells in ATMP Manufacturing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.